Maike Janssen

786 total citations
16 papers, 157 citations indexed

About

Maike Janssen is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Maike Janssen has authored 16 papers receiving a total of 157 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 4 papers in Oncology and 4 papers in Immunology. Recurrent topics in Maike Janssen's work include Acute Myeloid Leukemia Research (6 papers), CAR-T cell therapy research (3 papers) and Platelet Disorders and Treatments (3 papers). Maike Janssen is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), CAR-T cell therapy research (3 papers) and Platelet Disorders and Treatments (3 papers). Maike Janssen collaborates with scholars based in Germany, United States and China. Maike Janssen's co-authors include Carsten Müller‐Tidow, Martina Koch, Björn Nashan, Hansjörg Thude, Maximilian Felix Blank, Martina Sterneck, Michael Schmitt, Stefanie Göllner, Tim Sauer and Yi Liu and has published in prestigious journals such as Blood, International Journal of Cancer and Leukemia.

In The Last Decade

Maike Janssen

16 papers receiving 154 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maike Janssen Germany 9 48 43 41 33 22 16 157
Krisztián Kállay Hungary 9 65 1.4× 27 0.6× 53 1.3× 44 1.3× 13 0.6× 27 196
Ami Patel United States 9 66 1.4× 82 1.9× 27 0.7× 54 1.6× 34 1.5× 24 261
Veronica Tintori Italy 9 48 1.0× 31 0.7× 39 1.0× 75 2.3× 15 0.7× 19 204
Stephen DeWall United States 7 52 1.1× 124 2.9× 93 2.3× 31 0.9× 16 0.7× 12 227
Chantana Polprasert Thailand 9 78 1.6× 26 0.6× 77 1.9× 89 2.7× 12 0.5× 42 226
Chantiya Chanswangphuwana Thailand 8 69 1.4× 36 0.8× 35 0.9× 104 3.2× 14 0.6× 36 168
Christina C. Rolling Germany 8 34 0.7× 45 1.0× 71 1.7× 51 1.5× 19 0.9× 24 200
Caroline Dudreuilh United Kingdom 8 71 1.5× 33 0.8× 90 2.2× 11 0.3× 26 1.2× 17 230
Luděk Pour Czechia 8 69 1.4× 79 1.8× 51 1.2× 61 1.8× 16 0.7× 88 206
Alessandra Tesser Italy 9 23 0.5× 67 1.6× 93 2.3× 21 0.6× 10 0.5× 23 183

Countries citing papers authored by Maike Janssen

Since Specialization
Citations

This map shows the geographic impact of Maike Janssen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maike Janssen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maike Janssen more than expected).

Fields of papers citing papers by Maike Janssen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maike Janssen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maike Janssen. The network helps show where Maike Janssen may publish in the future.

Co-authorship network of co-authors of Maike Janssen

This figure shows the co-authorship network connecting the top 25 collaborators of Maike Janssen. A scholar is included among the top collaborators of Maike Janssen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maike Janssen. Maike Janssen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Huber, Karin, Swati Garg, Lixiazi He, et al.. (2025). Phosphatidic acid phosphatase LPIN1 in phospholipid metabolism and stemness in hematopoiesis and AML. HemaSphere. 9(4). e70118–e70118. 1 indexed citations
2.
Chen, Qian, Yao Hao, Brigitte Neuber, et al.. (2024). Proteasome inhibition enhances the anti-leukemic efficacy of chimeric antigen receptor (CAR) expressing NK cells against acute myeloid leukemia. Journal of Hematology & Oncology. 17(1). 85–85. 9 indexed citations
3.
Janssen, Maike, Albrecht Leo, Marie Bartenschlager, et al.. (2024). Treatment of chronic COVID‐19 with convalescent/postvaccination plasma in patients with hematologic malignancies. International Journal of Cancer. 155(4). 618–626. 8 indexed citations
4.
Schmidt, Christina, Christian Rohde, Cornelius Pauli, et al.. (2023). The ribosomal protein S6 kinase alpha-1 (RPS6KA1) induces resistance to venetoclax/azacitidine in acute myeloid leukemia. Leukemia. 37(8). 1611–1625. 14 indexed citations
5.
Janssen, Maike, et al.. (2023). Reduced proliferation of bone marrow MSC after allogeneic stem cell transplantation is associated with clinical outcome. Blood Advances. 7(12). 2811–2824. 2 indexed citations
6.
Stelmach, Patrick, Sarah Richter, Sandra Sauer, et al.. (2023). Clonal hematopoiesis with <i>DNMT3A</i> and <i>PPM1D</i> mutations impairs regeneration in autologous stem cell transplant recipients. Haematologica. 108(12). 3308–3320. 8 indexed citations
7.
Neuendorff, Nina Rosa, Lutz Frankenstein, Marietta Kirchner, et al.. (2023). Aspirin use and bleeding events during thrombocytopenia after autologous stem-cell transplantation for multiple myeloma. Frontiers in Oncology. 13. 1168120–1168120. 1 indexed citations
8.
Waclawiczek, Alexander, Stefanie Göllner, Daniel Heid, et al.. (2022). Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML. Leukemia. 36(10). 2418–2429. 12 indexed citations
9.
Pabst, Caroline, Louise Benning, Nora Liebers, et al.. (2022). Humoral Responses and Chronic GVHD Exacerbation after COVID-19 Vaccination Post Allogeneic Stem Cell Transplantation. Vaccines. 10(2). 330–330. 11 indexed citations
10.
Liu, Yi, Sanmei Wang, Maria‐Luisa Schubert, et al.. (2021). CD33‐directed immunotherapy with third‐generation chimeric antigen receptor T cells and gemtuzumab ozogamicin in intact and CD33‐edited acute myeloid leukemia and hematopoietic stem and progenitor cells. International Journal of Cancer. 150(7). 1141–1155. 35 indexed citations
11.
Renders, Simon, Aino‐Maija Leppä, Alexander Waclawiczek, et al.. (2021). Leukemic Stem Cells of Monocytic AMLs Are Not-Resistant to BCL-2 Inhibition. Blood. 138(Supplement 1). 3469–3469. 1 indexed citations
12.
Terzer, Tobias, Axel Benner, Sabine Goisser, et al.. (2021). Validation of a proxy‐reported SARC‐F questionnaire for current and retrospective screening of sarcopenia‐related functional impairments. Journal of Cachexia Sarcopenia and Muscle. 13(1). 264–275. 10 indexed citations
13.
Janssens, Ann, Yves Béguin, Catherine Lambert, et al.. (2019). PF694 TREATMENT‐FREE REMISSION AFTER TPO RECEPTOR AGONISTS IN ADULT ITP PATIENTS IN BELGIUM. HemaSphere. 3(S1). 301–301. 1 indexed citations
14.
Janssen, Maike, Friedrich Thaiss, Björn Nashan, Martina Koch, & Hansjörg Thude. (2019). Donor derived HLA-G polymorphisms have a significant impact on acute rejection in kidney transplantation. Human Immunology. 80(3). 176–183. 10 indexed citations
15.
Thude, Hansjörg, Maike Janssen, Martina Sterneck, Björn Nashan, & Martina Koch. (2016). 14-bp ins/del polymorphism and +3142C>G SNP of the HLA-G gene have a significant impact on acute rejection after liver transplantation. Human Immunology. 77(12). 1159–1165. 18 indexed citations
16.
Janssen, M., Peter Lucassen, Floris van de Laar, Maike Janssen, & E.H. van de Lisdonk. (2008). Systemic corticosteroids for acute gout (Review). 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026